GGrantIndex
← Leaderboards

Sheng Pan

Baylor College Of Medicine

$3,505,701
Attributed
$6,399,378
Total exposure
6
Grants
2
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $944.9K · FY201025
$1M$750K$500K$250K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$6,399,378 · 6

By mechanism

R01$4,769,503 · 2
K25$612,023 · 1
R21$396,128 · 1
UH3$328,995 · 1
UH2$292,729 · 1

Top collaborators

Most similar at Baylor College Of Medicine

Same institution · by research overlap

Others in their field

Top investigators on “Proteomics

Research focus

ProteomicsMalignant NeoplasmsSamplingTechnologyInvestigationCohortBloodMalignant Neoplasm Of PancreasDiagnosisPlasmaEarly DiagnosisClinical ResearchCancer PatientBaseCessation Of LifeCancer EtiologyProteinsTumor ProgressionMolecularInterestStagingDetectionDiagnosticLead

Grant awards (18)

Elucidating the role of gut microbiota in colitis-associated colorectal cancer$615,878
R01 · FY2025 · CA
BLOOD-BASED PROTEOMIC ASSAY FOR PANCREATIC CANCER DETECTION$328,995
UH3 · FY2025 · CA
Elucidating the role of gut microbiota in colitis-associated colorectal cancer$585,084
R01 · FY2024 · CA
BLOOD-BASED PROTEOMIC ASSAY FOR PANCREATIC CANCER DETECTION$292,729
UH2 · FY2024 · CA
Elucidating the role of gut microbiota in colitis-associated colorectal cancer$649,138
R01 · FY2023 · CA
Early detection of pancreatic cancer in diabetics$534,119
R01 · FY2018 · CA
Early detection of pancreatic cancer in diabetics$50,409
R01 · FY2018 · CA
Early detection of pancreatic cancer in diabetics$587,611
R01 · FY2017 · CA
Early detection of pancreatic cancer in diabetics$574,199
R01 · FY2016 · CA
Early detection of pancreatic cancer in diabetics$572,954
R01 · FY2015 · CA
Early detection of pancreatic cancer in diabetics$600,111
R01 · FY2014 · CA
Quantitative glycoproteomics for pancreatic cancer studies$123,122
K25 · FY2014 · CA · contact PI
Quantitative glycoproteomics for pancreatic cancer studies$123,122
K25 · FY2013 · CA · contact PI
Aberrant Glycosylation Signature in Pancreatic Cancer$208,128
R21 · FY2012 · CA · contact PI
Quantitative glycoproteomics for pancreatic cancer studies$123,122
K25 · FY2012 · CA · contact PI
Aberrant Glycosylation Signature in Pancreatic Cancer$188,000
R21 · FY2011 · CA · contact PI
Quantitative glycoproteomics for pancreatic cancer studies$123,122
K25 · FY2011 · CA · contact PI
Quantitative glycoproteomics for pancreatic cancer studies$119,535
K25 · FY2010 · CA · contact PI